ZTS Zoetis Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ZTS

Price (delayed)

$146.5

Market cap

$67.08B

P/E Ratio

28.84

Dividend/share

$1.61

EPS

$5.08

Enterprise value

$71.79B

Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's ...

Highlights
The P/E is 27% lower than the 5-year quarterly average of 41.1 and 19% lower than the last 4 quarters average of 37.0
The debt fell by 17% YoY
Zoetis's quick ratio has increased by 17% YoY but it has decreased by 5% QoQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.zoetis.com/
Peers: PFE MRK LLY ICCC

Key stats

What are the main financial stats of ZTS
Market
Shares outstanding
457.87M
Market cap
$67.08B
Enterprise value
$71.79B
Valuations
Price to earnings (P/E)
28.84
Price to book (P/B)
13.46
Price to sales (P/S)
7.91
EV/EBIT
22.58
EV/EBITDA
19.56
EV/Sales
8.4
Earnings
Revenue
$8.54B
EBIT
$3.18B
EBITDA
$3.67B
Free cash flow
$1.63B
Per share
EPS
$5.08
Free cash flow per share
$3.52
Book value per share
$10.88
Revenue per share
$18.53
TBVPS
$22.09
Balance sheet
Total assets
$14.29B
Total liabilities
$9.3B
Debt
$6.76B
Equity
$5B
Working capital
$4.45B
Liquidity
Debt to equity
1.35
Current ratio
3.36
Quick ratio
1.77
Net debt/EBITDA
1.28
Margins
EBITDA margin
43%
Gross margin
70%
Net margin
27.4%
Operating margin
37.2%
Efficiency
Return on assets
16.8%
Return on equity
48.8%
Return on invested capital
24.5%
Return on capital employed
25.6%
Return on sales
37.2%
Dividend
Dividend yield
1.1%
DPS
$1.61
Payout ratio
31.8%

ZTS stock price

How has the Zoetis stock price performed over time
Intraday
-4.32%
1 week
-2.32%
1 month
-15.3%
1 year
-16.28%
YTD
-25.77%
QTD
-13.42%

Financial performance

How have Zoetis's revenue and profit performed over time
Revenue
$8.54B
Gross profit
$5.98B
Operating income
$3.18B
Net income
$2.34B
Gross margin
70%
Net margin
27.4%
The net income has grown by 11% YoY and by 2.8% from the previous quarter
Zoetis's operating income has increased by 10% YoY
ZTS's revenue is up by 6% YoY and by 2.1% QoQ
The gross profit has grown by 6% YoY

Growth

What is Zoetis's growth rate over time

Valuation

What is Zoetis stock price valuation
ZTS P/E details
P/E
28.84
P/B
13.46
P/S
7.91
EV/EBIT
22.58
EV/EBITDA
19.56
EV/Sales
8.4
The P/E is 27% lower than the 5-year quarterly average of 41.1 and 19% lower than the last 4 quarters average of 37.0
Zoetis's EPS has increased by 13% YoY and by 3.3% QoQ
The stock's price to book (P/B) is 28% less than its 5-year quarterly average of 19.6 and 18% less than its last 4 quarters average of 17.1
ZTS's equity is up by 13% year-on-year
ZTS's price to sales (P/S) is 21% lower than its 5-year quarterly average of 10.5 and 17% lower than its last 4 quarters average of 9.9
ZTS's revenue is up by 6% YoY and by 2.1% QoQ

Efficiency

How efficient is Zoetis business performance
ZTS's return on assets is up by 12% year-on-year and by 4.3% since the previous quarter
ZTS's ROIC is down by 6% YoY
The company's return on equity rose by 6% YoY
Zoetis's return on sales has increased by 4.5% YoY

Dividends

What is ZTS's dividend history
Dividend details
DPS
$1.61
Dividend yield
1.1%
Payout ratio
31.8%
Recent dividends

Financial health

How did Zoetis financials performed over time
ZTS's total assets is 54% greater than its total liabilities
The company's current ratio rose by 42% YoY but it fell by 13% QoQ
Zoetis's quick ratio has increased by 17% YoY but it has decreased by 5% QoQ
The debt is 35% higher than the equity
Zoetis's debt to equity has decreased by 27% YoY
The debt fell by 17% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.